One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Access
PDF Availablehttps://doi.org/10.1016/s1556-0864(21)01985-7
Copy DOI
Export
Save
Share
Cite Journal: Journal of Thoracic Oncology |  Publication Date: Mar 27, 2021 |
Affiliation: Saint Luke's Hospital, Samsung Medical Center, Taipei Veterans General Hospital, University of California, Davis, University of Sydney, Princess Margaret Cancer Centre, University of Chieti-Pescara, University College London, Adelphi Group (United Kingdom), AstraZeneca (United States), AstraZeneca (United Kingdom), Carl von Ossietzky University of Oldenburg
143P Physician perceptions of barriers to epidermal growth factor receptor mutation (EGFRm) testing in advanced (stage IIIb/IIIc/IV) non-small cell lung cancer (NSCLC)
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
